Key statistics
On Friday, Orion Oyj (0M2O:LSE) closed at 45.03, -10.05% below its 52-week high of 50.06, set on Sep 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 44.98 |
---|---|
High | 45.03 |
Low | 45.03 |
Bid | 44.15 |
Offer | 45.97 |
Previous close | 44.94 |
Average volume | 83.51k |
---|---|
Shares outstanding | 141.13m |
Free float | 126.69m |
P/E (TTM) | 19.14 |
Market cap | 6.35bn EUR |
EPS (TTM) | 2.36 EUR |
Annual div (ADY) | 1.62 EUR |
---|---|
Annual div yield (ADY) | 3.60% |
Div ex-date | Oct 15 2024 |
Div pay-date | Oct 23 2024 |
Data delayed at least 20 minutes, as of Nov 08 2024 17:33 GMT.
More ▼
- Orion Corporation: Managers’ transactions – Henrik Stenqvist
- Orion Oyj: Johtohenkilöiden liiketoimet – Henrik Stenqvist
- Orion Group Interim Report January–September 2024
- Orion-konsernin osavuosikatsaus tammi–syyskuu 2024
- Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
- Sisäpiiritieto: Orion lopettaa ODM-111-kehitysohjelman perustuen molekyylin liian kapeaan terapeuttiseen ikkunaan
- Orion julkaisee osavuosikatsauksen 1–9/2024 ja järjestää verkkolähetyksen 29.10.2024
- Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
- Orionin yhteistyökumppani Bayer hakee EU:ssa kolmatta indikaatiota darolutamidille
- Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
More ▼